Summary
Axon Enterprise, Inc. reported its second-quarter 2020 financial results, showcasing robust revenue growth driven by strong performance in both its TASER and Software and Sensors segments. Net sales increased by 25.7% year-over-year to $141.3 million. However, the company reported a net loss of $30.8 million for the quarter, a significant shift from the $0.7 million net income in the prior year's quarter. This loss was largely influenced by a substantial increase in stock-based compensation expense, primarily related to performance awards, and increased legal expenses associated with the FTC litigation. Despite the net loss, the company highlighted a healthy increase in gross margin to 62.4% and a strong liquidity position with $319.3 million in cash and cash equivalents. The company's strategic shift towards a subscription-based model continues, with significant future contracted revenues totaling approximately $1.34 billion. Management expressed confidence in their ability to navigate the COVID-19 pandemic due to supply chain diversification and proactive measures. Key growth drivers include the new TASER 7 devices and cartridges, alongside continued expansion in cloud-based evidence management and body camera solutions.
Financial Highlights
49 data points| Revenue | $141.26M |
| Cost of Revenue | $53.08M |
| Gross Profit | $88.18M |
| R&D Expenses | $29.56M |
| SG&A Expenses | $72.29M |
| Operating Expenses | $101.85M |
| Operating Income | -$13.68M |
| Net Income | -$30.76M |
| EPS (Basic) | $-0.51 |
| EPS (Diluted) | $-0.51 |
| Shares Outstanding (Basic) | 60.35M |
| Shares Outstanding (Diluted) | 60.35M |
Key Highlights
- 1Net sales grew 25.7% year-over-year to $141.3 million, driven by both product and service revenue increases.
- 2Gross margin improved significantly to 62.4% from 58.4% in the prior year's quarter, indicating better cost management and product mix.
- 3The company reported a net loss of $30.8 million, a stark contrast to a net income of $0.7 million in Q2 2019, largely due to increased stock-based compensation and legal expenses.
- 4Stock-based compensation expense surged by $21.8 million year-over-year, primarily due to the probable achievement of performance goals for CEO and XSPP awards.
- 5Remaining performance obligations (future contracted revenue) stood at a substantial $1.34 billion as of June 30, 2020.
- 6Cash and cash equivalents increased to $319.3 million, demonstrating a strong liquidity position.
- 7The Software and Sensors segment continued its strong growth trajectory, with net sales up 36.6% year-over-year.